JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hakan Akintürk
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schranz, D.
Right arrow Articles by Akintürk, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Schranz, D.
Right arrow Articles by Akintürk, H.

J Thorac Cardiovasc Surg 2007;134:796-797
© 2007 The American Association for Thoracic Surgery

Brief Communication

Pulmonary artery banding for idiopathic dilative cardiomyopathy: A novel therapeutic strategy using an old surgical procedure

Dietmar Schranz, MD*, Alex Veldman, MD, Ulrike Bartram, MD, Ina Michel-Behnke, MD, Jürgen Bauer, MD, Hakan Akintürk, MD

Pediatric Heart Center, Justus-Liebig University, Giessen, Germany.

Received for publication April 6, 2007; accepted for publication April 16, 2007.

* Reprint requests: Dietmar Schranz, MD, Pediatric Heart Center, Justus-Liebig University Feulgenstrasse 12, 35385 Giessen, Germany. (Email: Dietmar.Schranz@paediat.med.uni-giessen.de).

The first 20% of the full text of this article appears below.


Figure 1
Prof Dr Schranz


A 2-month-old infant with progressive idiopathic dilative cardiomyopathy (iDCM) who was listed for heart transplantation recovered dramatically from end-stage heart failure after pulmonary artery banding (PAB). To our knowledge, the use of PAB to treat left-sided iDCM has not been described in the literature.

Clinical Summary

The patient presented during fetal life with massive dilation and reduced systolic function of the left ventricle (LV). At 35 weeks of gestation, delivery became necessary because of progressive deterioration of heart function. A postnatal echocardiogram showed an extremely dilated LV (Figure 1, A) with an ejection fraction of 13%. The male newborn (weight 2370 g) was treated with controlled ventilation, inotropics, and prostaglandin E1 for contribution of the right ventricle (RV) to cardiac output through the arterial duct. When secondary causes of dilative cardiomyopathy were ruled out, the patient was listed for heart transplantation; 2 months after this, we decided to perform a . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.